Blood Group Typing Market (Technique - PCR-based and Microarray Technique, Massively Parallel Sequencing, Assay-based Techniques, and Other Techniques; Test Type - Human Leukocyte Antigen (HLA) Typing, Antibody Screening, ABO Blood Tests, Cross-matching Series, and Antigen Typing; Product Type - Instruments, Services, and Consumables; End User - Clinical Laboratories, Blood Banks, Hospitals, and Other End Users): Global Industry Analysis, Trends, Size, Share and Forecasts to 2026

A recent report published by Infinium Global Research on the blood group typing market provides an in-depth analysis of segments and sub-segments in the global as well as regional blood group typing market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional blood group typing market over the short term as well as the long term. The report is a comprehensive presentation of trends, forecasts, and dollar values of the global blood group typing market. According to the report, the global blood group typing market is projected to grow at a CAGR of 10.00% over the forecast period of 2020-2026.

Market Insight

The global blood group typing market is likely to grow with a CAGR of 10.00% throughout the forecast period. Accurate grouping of blood is very vital when it comes to having a blood transfusion. Blood group typing depends upon the nature and the existence of antigens in the red blood cells. Blood group typing is an important test that helps to identify the resemblance of the donor with the receiver during the blood transfusion or organ donation procedure. Improvement in the blood detection technique improved the growth of the market. 

An increasing number of blood donations blood donation campaigns and a rise in the number of blood transfusions are the major factors driving the growth of the blood group typing market globally. An increase in the number of blood cancers such as lymphoma, leukemia, and myeloma, and blood-related diseases has increased the number of blood transfusions and organ replacement. Furthermore, a growing number of road accidents and trauma and an increasing number of blood tests for blood transfusion is also boosting the growth of the market. Additionally, the rising importance of blood group typing during pregnancy is another key factor driving the market growth. However, the lack of trained professionals in low- and middle-income countries hinders the growth of the blood group typing market. On the other hand, transforming healthcare infrastructure in emerging markets with an increasing number of healthcare facilities as well as growing advancements in the blood group typing systems will provide beneficial growth opportunities for the players operating in the market

In terms of region, North America dominates the market and is likely to hold the highest share of the market during the forecast period. This is primarily due to the rising occurrence of chronic diseases in the region. Furthermore, the presence of better healthcare infrastructure in the region also boosts the growth of the blood group typing market. Moreover, Europe is anticipated to be the second-largest region in the blood group market during the forecast period. The presence of several reimbursement ventures for various surgeries and the occurrence of several chronic diseases are the key factors for the growth of the blood group typing market in the European region. Meanwhile, Asia Pacific is expected to be the fastest-growing region in this market over the forecast period. This is mainly due to the growing prevalence of infectious diseases. Moreover, an increasing number of accidents and surgeries are anticipated to boost the growth of the market in the region

Segment Covered

The report on the global blood group typing market covers segments such as technique, test type, product type, and end user. On the basis of technique, the sub-markets include PCR-based and microarray technique, massively parallel sequencing, assay-based techniques, and other techniques. On the basis of test type, the sub-markets include Human Leukocyte Antigen (HLA) typing, antibody screening, ABO blood tests, cross-matching series, and antigen typing. On the basis of product type, the sub-markets include instruments, services, and consumables. On the basis of end user, the sub-markets include clinical laboratories, blood banks, hospitals, and other end users.

Companies Profiled:

The report provides profiles of the companies in the market such as Quotient Limited, Immucor, Inc., DIAGAST, Novacyt Group, Agena Bioscience, Inc., BAG Health Care GmbH, AXO Science, Ortho Clinical Diagnostics, Inc., Rapid Labs, and others.

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the blood group typing market. Moreover, the study highlights current market trends and provides forecasts from 2020-2026. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.